These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19092295)

  • 1. RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.
    Siraj AK; Al-Rasheed M; Ibrahim M; Siddiqui K; Al-Dayel F; Al-Sanea O; Uddin S; Al-Kuraya K
    J Endocrinol Invest; 2008 Oct; 31(10):893-9. PubMed ID: 19092295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.
    Siraj AK; Ibrahim M; Al-Rasheed M; Abubaker J; Bu R; Siddiqui SU; Al-Dayel F; Al-Sanea O; Al-Nuaim A; Uddin S; Al-Kuraya K
    BMC Med Genet; 2008 Jul; 9():61. PubMed ID: 18601742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of differentiated thyroid carcinoma with combined effects of homologous recombination repair gene polymorphisms in an Iranian population.
    Fayaz S; Karimmirza M; Tanhaei S; Fathi M; Torbati PM; Fard-Esfahani P
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6727-31. PubMed ID: 24377596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.
    Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B
    Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.
    Chen P; Sun R; Pu Y; Bai P; Yuan F; Liang Y; Zhou B; Wang Y; Sun Y; Zhu J; Zhang L; Gao L
    Medicine (Baltimore); 2015 Sep; 94(38):e1536. PubMed ID: 26402809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-repair genetic polymorphisms and breast cancer risk.
    Smith TR; Levine EA; Perrier ND; Miller MS; Freimanis RI; Lohman K; Case LD; Xu J; Mohrenweiser HW; Hu JJ
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1200-4. PubMed ID: 14652281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk.
    Lee KM; Choi JY; Kang C; Kang CP; Park SK; Cho H; Cho DY; Yoo KY; Noh DY; Ahn SH; Park CG; Wei Q; Kang D
    Clin Cancer Res; 2005 Jun; 11(12):4620-6. PubMed ID: 15958648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma.
    Akulevich NM; Saenko VA; Rogounovitch TI; Drozd VM; Lushnikov EF; Ivanov VK; Mitsutake N; Kominami R; Yamashita S
    Endocr Relat Cancer; 2009 Jun; 16(2):491-503. PubMed ID: 19286843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand.
    Kietthubthew S; Sriplung H; Au WW; Ishida T
    Int J Hyg Environ Health; 2006 Jan; 209(1):21-9. PubMed ID: 16373199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the influence of chronic low-dose radiation on DNA repair gene polymorphisms [
    Saini D; Sudheer KR; Kumar PRV; Soren DC; Jain V; Koya PKM; Jaikrishan G; Das B
    Int J Radiat Biol; 2020 Jun; 96(6):734-739. PubMed ID: 32149571
    [No Abstract]   [Full Text] [Related]  

  • 11. XRCC3 and NBS1 gene polymorphisms modulate the risk of pre-oral cancer and oral cancer in the North Indian population.
    Nigam K; Gupta S; Singh N; Yadav SK; Sanyal S
    J Cancer Res Ther; 2023; 19(2):304-311. PubMed ID: 37006067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic polymorphisms in X-ray repair cross-complementing gene 1 and susceptibility to papillary thyroid carcinoma].
    Zhu QX; Bian JC; Shen Q; Jiang F; Tang HW; Zhang HW; Wu Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):702-5. PubMed ID: 15555397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
    Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Ile3434Thr XRCC7 gene polymorphism in differentiated thyroid cancer risk in an Iranian population.
    Rahimi M; Fayaz S; Fard-Esfahani A; Modarressi MH; Akrami SM; Fard-Esfahani P
    Iran Biomed J; 2012; 16(4):218-22. PubMed ID: 23183621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VDR gene FokI polymorphism as a poor prognostic factor for papillary thyroid cancer.
    Beysel S; Eyerci N; Pinarli FA; Apaydin M; Kizilgul M; Caliskan M; Ozcelik O; Kan S; Cakal E
    Tumour Biol; 2018 Nov; 40(11):1010428318811766. PubMed ID: 30486759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.
    Improta G; Sgambato A; Bianchino G; Zupa A; Grieco V; La Torre G; Traficante A; Cittadini A
    Anticancer Res; 2008; 28(5B):2941-6. PubMed ID: 19031937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of DNA repair genes and risk of glioma.
    Wang LE; Bondy ML; Shen H; El-Zein R; Aldape K; Cao Y; Pudavalli V; Levin VA; Yung WK; Wei Q
    Cancer Res; 2004 Aug; 64(16):5560-3. PubMed ID: 15313891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphic variants of DNA repair gene XRCC3 and XRCC7 and risk of prostate cancer: a study from North Indian population.
    Mandal RK; Kapoor R; Mittal RD
    DNA Cell Biol; 2010 Nov; 29(11):669-74. PubMed ID: 20590474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-strand break repair and colorectal cancer: gene variants within 3' UTRs and microRNAs binding as modulators of cancer risk and clinical outcome.
    Naccarati A; Rosa F; Vymetalkova V; Barone E; Jiraskova K; Di Gaetano C; Novotny J; Levy M; Vodickova L; Gemignani F; Buchler T; Landi S; Vodicka P; Pardini B
    Oncotarget; 2016 Apr; 7(17):23156-69. PubMed ID: 26735576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variants in DNA double-strand break repair genes and breast cancer susceptibility.
    Kuschel B; Auranen A; McBride S; Novik KL; Antoniou A; Lipscombe JM; Day NE; Easton DF; Ponder BA; Pharoah PD; Dunning A
    Hum Mol Genet; 2002 Jun; 11(12):1399-407. PubMed ID: 12023982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.